bosentan

FDA Drug Profile — Tracleer, bosentan

bosentan is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including Tracleer, bosentan. Available dosage forms: tablet, for suspension, tablet, film coated.

Drug details

Generic Name
bosentan
Brand Names
Tracleer, bosentan
Application Number
NDA209279
Sponsor
Actelion Pharmaceuticals US, Inc.
NDC Codes
9
Dosage Forms
TABLET, FOR SUSPENSION, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
BOSENTAN

Indications and Usage

1 INDICATIONS AND USAGE Bosentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): in adults to improve exercise ability and to decrease clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (60%), PAH associated with connective tissue diseases (21%), and PAH associated with congenital heart disease with left-to-right shunts (18%) [see Clinical Studies ( 14.1 )] . in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability. Bosentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): in adults to improve exercise ability and to decrease clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (60%), PAH associated with connective tissue diseases (21%), and PAH associated with congenital heart disease with left-to-right shunts (18%) ( 1 ). in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.